Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Effect of Calcium Hydroxide vs. Tobradex Intracanal Medicament on Postoperative Endodontic Pain: A Prospective Trial

NCT07332936 is registered in ClinicalTrials.gov with Umm Al-Qura University as lead sponsor.

NCT NCT07332936
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07332936 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Effect of Calcium Hydroxide vs. Tobradex Intracanal Medicament on Postoperative Endodontic Pain: A Prospective Trial
Lead sponsor
Umm Al-Qura University
Phase
Not applicable
Overall status
Completed
Start date
July 1, 2023
Completion date
June 30, 2024
Enrollment
43 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

postoperative endodontic pain following emergency root canal treatment, symptomatic irreversible pulpitis